Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
67 Cards in this Set
- Front
- Back
Human microbiome project |
Project of the national Institutes of Health to identify microbial inhabitants of the human body and their role in the health and disease; uses metagenomic techniques instead of culturing. |
|
Abscess |
An inflamed fibrous lesion enclosing a core of pus |
|
Adhesion |
The process by which microbes gain a more stable foothold at the portal of entry; often involves a specific interaction between the molecules of the microbial surface interceptors on the host cell |
|
Bacteremia |
The presence of viable bacteria in circulating blood |
|
Carrier |
A person who Harbors infections and inconspicuously spreads them to others. Also a chemical agent that can accept an atom, chemical radical, or sub atomic particle from one compound and pass it on to another |
|
Common source epidemic |
An outbreak of disease in which all affected individuals were exposed to a single source of the pathogen, even if they were exposed to from times |
|
Communicable |
An infection that can be passed from one individual to another |
|
Contagious |
Communicable ;transmissible by direct contact with infected people and their fresh secretions or excretions |
|
Convalescence period |
The period After a clinical infection when the infected individual is recovering from an illness in resolving symptoms |
|
Edema |
The accumulation of fluid in cells, tissues, or serious cavities. Also called swelling |
|
Endotoxin |
A bacterial toxin that is not ordinarily released ( as is exotoxin ). It is composed of a phospholipid saccharide complex that is an integral part of gram-negative bacterial cell walls and can cause severe shock and fever |
|
Epidemic |
A sudden and simultaneous outbreak or increase in the number of cases of disease in a community |
|
Epidemiology |
The study of the factors affecting the prevalence and spread of disease within a community |
|
Etiological agent |
The microbial cause of disease; the pathogen |
|
Exoenzymes |
An extracellular enzyme chiefly for hydrolysis of nutrient macromolecules. These molecules function in decomposition of organic degrees and can be a factor in invasiveness of pathogens |
|
Exogenesis |
Originating outside the body |
|
Exotoxin |
A toxin (usually protein) that is secreted and acts upon a specific cellular Target. Examples include: botulin, tetanospasmin, diphtheria Toxin, and erythrogenic toxin |
|
Granuloma |
A solid mass or nodule of inflammatory tissue containing modified macrophages and lymphocytes. Usually a chronic pathologic process of diseases such as tuberculosis or syphilis |
|
Hemolysin |
Any biological agent that is capable of destroying red blood cells in causing the release of hemoglobin. Many bacterial pathogens produce exotoxins that act as hemolysins |
|
Hemolysis |
The release of hemoglobin that occurs when red blood cells burst |
|
Incidence |
In epidemiology the number of cases of a disease occurring during a period |
|
Incubation period |
The period from the initial contact with an infectious agent to the appearance of the first symptoms |
|
Index case |
The first case of disease identified in an outbreak or epidemic |
|
Infectious disease |
The state of damage or toxicity in the body caused by an infectious agent |
|
Inflammation |
a natural, nonspecific response to tissue injury that protects the host from further damage. It stimulates immune reactivity and blocks the spread of an infectious agent |
|
Koch's postulates |
A procedure to establish the specific cause of disease. In all cases of Infection: (1) the agent must be found; (2) inoculations of pure culture must reproduce the same disease in animals;(3) the agent must again be present in the experimental animal; and (4) a pure culture must again be obtained |
|
Latency |
The state of being inactive. Example: of latent virus latent infection |
|
Leukocidin |
The Heat-liable protein produced by bacteria that impairs and sometime lysis leukocytes |
|
Leukocytosis |
An abnormally large number of leukocytes in blood which can be indicative of acute infection |
|
Leukopenia |
A lower than normal leukocyte count in the blood that can be indicative of blood infection or disease |
|
Lymphadenitis |
Inflammation of 1 or more lymph nodes. Also called lymphadenopathy |
|
Metagenomics |
The study of all the genomes in a particular biological niche, as opposed to individual genomes from single species |
|
Microbial antagonism |
Relationship in which microorganisms compete for survival in a common environment by taking actions that inhibit or destroy another organism |
|
Morbidity rates |
The number of persons afflicted with an illness under question or with illness in general ; Expressed as a numerator with the denominator of being some unit of population (as in X / 100,000) |
|
Mortality rate |
The number of persons who have died as the result of a particular cause or due to all causes; expressed as a numerator, with the denominator being some unit of the population (As in X / 100,000) |
|
Point Source Epidemic |
An outbreak of disease in which all affected individuals were exposed to a single source of the pathogen at a single point in time. |
|
portal of entry |
Route of entry for an infectious agent. |
|
portal of exit |
Route through which a pathogen departs from the host organism. |
|
prevalence |
The total number of cases of a disease in a certain area and time period. |
|
prodromal stage |
A short period of mild symptoms occurring at the end of the period of incubation. It indicates the onset of disease. |
|
propagated epidemic |
An outbreak of disease in which the causative agent is passed from affected persons to new persons over the course of time. |
|
reportable disease |
Those diseases that must be reported to health authorities by law. |
|
reservoir |
In disease communication, the natural host or habitat of a pathogen. |
|
septicemia |
Systemic infection associated with microorganisms multiplying in circulating blood. |
|
sequela |
A morbid complication that follows a disease. |
|
sign |
Any abnormality uncovered upon physical diagnosis that indicates the presence of disease. It is an objective assessment of disease. |
|
sporadic |
Description of a disease that exhibits new cases at irregular intervals in unpredictable geographic locales. |
|
symptom |
The subjective evidence of infection and disease as perceived by the patient. |
|
syndrome |
The collection of signs and symptoms that, taken together, paint a portrait of the disease. |
|
toxin |
A specific chemical product of microbes, plants, and some animals that is poisonous to other organisms. |
|
transmitter |
The individual or object from which an infection is actually acquired. |
|
true pathogen |
A microbe capable of causing infection and disease in healthy persons with normal immune defenses. |
|
universal precautions (UPs) |
Centers for Disease Control and Prevention guidelines for health care workers regarding the prevention of disease transmission when handling patients and body substances. |
|
viremia |
The presence of viruses in the bloodstream. |
|
virulence |
In infection, the relative capacity of a pathogen to invade and harm host cells. |
|
virulence factors |
A microbe’s structures or capabilities that allow it to establish itself in a host and cause damage. |
|
zoonosis |
An infectious disease indigenous to animals that humans can acquire through direct or indirect contact with infected animals. |
|
Necrosis |
A pathological process in which cells and tissue die and disintegrate |
|
Non-communicable |
An infectious disease that is not transmitted from host to host |
|
Normal biota |
The native microbial forms that an individual harbors |
|
Nosocomial infection |
An infection not present upon admission to a hospital, but incurred while being treated there |
|
Opportunistic pathogen |
An infection, ordinarily non-pathogenic or weakly pathogenic microbes that cause disease primarily in an immunological compromised host |
|
Pandemic |
A disease affecting an increased proportion of the population over a wide geographic area (often worldwide) |
|
Pathogen |
Any agents (usually a virus, bacterium, fungus, protozoan, or helminth) that causes disease |
|
Pathogenicity |
The capacity of microbes to cause disease |
|
Period of invasion |
Period during a clinical infection when the Infectious agent multiplies at high levels, exhibit its greatest toxicity, and becomes well established in the target tissues |
|
Phagocyte |
A class of white blood cells capable of engulfing other cells and particles |